Abstract
Objective
The aim of this study was to evaluate clinical efficacy of nutritional therapy with Kabiven PI and ω-3 fish oil fat emulsion on advanced stage of malignant tumor.
Methods
One hundred and fifity-seven patients with advanced stage of malignant tumor were performed parenteral nutrition and enteral nutritional adjunctive therapy with Kabiven PI and ω-3 fish oil fat emulsion (according to the amount to heat of 20 kcal/kg a day and the nitrogen of 7g/m2·SA).
Results
The ECOG ≥ 3 of 103 cases, therapy interval 2–3 weeks, declined 1 score. 28 were performed with chemotherapeutics under nutritional therapy 2–4 periodical. 25 of 26 died were dead for cancer cachexia and multiple organ failure. Survival time was 2–7 months. No serious complications occurred in all patients.
Conclusion
The symptom and quality of life of advanced stage of malignant tumor were obviously improve by nutritional therapy. The opportunity for therapy tumor was offered. It is a important method on combined therapy of malignant tumor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Zhao J, Wang ChY, Yang AJ, et al. Vasculogenic mimicry formation in hepatocellular carcinoma. Chinese-German J Clin Oncol, 2006, 5: 43–45.
Bozzetti F. Total nutrition therapy of cancer. Curr Opin Support Palliat Care, 2007, 1: 281–286.
Huhmann MB, August DA. Review of American Society for Parenteral and Enteral Nutrition (ASPEN) clinical guidelines for mutrition support in cancer patients nutrition screening and assessment. Nutr Clin Pract, 2008, 23: 182–188.
Li JS. Clinical nutrition trends. Parenter Enteral Nutr, 2010, 1: 1–4.
Augustsson K, Michand DS, Rimm EB, et al. A prospective study of in take of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev, 2003, 12: 64–67.
Furst P, Kuhn KS. Fish oil emulsions: what benefits can they bring? Clin Nutr, 2000, 19: 7–14.
Heller AR, Rossel T, Gottsschlich B, et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer, 2004, 111: 611–616.
Heller A, Koch T, Schmeck J, et al. Lipid mediators in inflammatory disorders. Drugs, 1998, 55: 487–496.
Lee JY, Plakidas A, Lee WH, et al. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by ω-3 polyunsaturated fatty acids. J Lipid Res, 2003, 44: 479–486.
Lin HG, Li N, Wang XY, et al. Effrct of SMOF fat emulsion of fatty acid profile and inflammatory mediator of in major abdominal surgical patients. Parenter Enteral Nutr, 2010, 17: 195–198.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liang, J., Li, S., Bao, B. et al. A clinical analysis of nutritional therapy in 157 cases with advanced malignancy. Chin. -Ger. J. Clin. Oncol. 10, 734–736 (2011). https://doi.org/10.1007/s10330-011-0888-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-011-0888-2